PPARG and polycystic ovary syndrome: Additionally, Shi et al. suggested a significantly higher expression of PPARγ splice variants in PCOS patients, alongside more profound clinical features [73], while Giandalia et al. evaluated 53 PCOS patients and 26 control women and underlined the similar distribution of PPARγ exon 2 and exon 6 variants in the two groups.